Info
AE_GLIVEC
**nausea and vomiting (40-50%), mild to moderate transient ankle and periorbital edema, occasional myalgias, fluid retention with pleural effusion, ascites, pulmonary edema, and weight gain, diarrhea (25-30%), myelosuppression (weekly⇒biweekly⇒periodically), erythema multiforme and possible Stevens-Johnson syndrome but rare **Neuromuscular & skeletal: Muscle cramps (16% to 62%), musculoskeletal pain (adults: 38% to 49%; children: 21%), arthralgia (11% to 40%), myalgia (9% to 32%), weakness (?21%), back pain (?17%), limb pain (?16%), ostealgia (?11%)
Siblings
- AE_ABVD
- AE_ACT
- AE_ALECTINIB
- AE_ALIMTA
- AE_ALPELISIB
- AE_BENDAMUSTINE
- AE_CCRT
- AE_CDK46
- AE_CRIZOINIB
- AE_DABRAFENIB
- AE_ENHERTU
- AE_ERIBULIN
- AE_FOLFOX
- AE_GLIVEC
- AE_HERCEPTIN
- AE_LANREOTIDE
- AE_LAPATINIB
- AE_LAR
- AE_LETROZOLE
- AE_OLAPARIB
- AE_OSIMERTINIB
- AE_PAZOPANIB
- AE_PEMIGATINIB
- AE_PERTUZUMAB
- AE_RAMUCIRUMAB
- AE_RECTAL
- AE_REGORAFENIB
- AE_SORAFENIB
- AE_SUNITINIB
- AE_TAS102
- AE_TAXOTERECDDP
- AE_TOPOTECAN
- AE_UFT
- AE_VEMURAFENIB
- AE_VINORELBINE
- AE_XELOX